Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
25%
Ph phase_3
2
25%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Active, not recruiting2
Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
Phase 32 (40.0%)

Trials by Status

unknown338%
withdrawn113%
active_not_recruiting225%
completed225%

Recent Activity

2 active trials
Showing 5 of 8
active_not_recruitingphase_3

Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

NCT02089100
active_not_recruitingphase_1

RT for Adenocarcinoma/Adenosquamous Carcinoma

NCT07153952
completed

Survival Analysis: TACE vs. Combination Therapy in HCC

NCT06261138
completedphase_3

The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer

NCT01606098
unknownphase_2

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

NCT04135690
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02089100Phase 3

Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

Active Not Recruiting
NCT07153952Phase 1

RT for Adenocarcinoma/Adenosquamous Carcinoma

Active Not Recruiting
NCT06261138

Survival Analysis: TACE vs. Combination Therapy in HCC

Completed
NCT01606098Phase 3

The Role of Surgery of the Primary Tumour in Patients With Synchronous Unresectable Metastases of Colorectal Cancer

Completed
NCT04135690Phase 2

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Unknown
NCT04283396

Study for Novel Coronavirus Pneumonia (NCP)

Unknown
NCT02251353

Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients

Unknown
NCT03323424Phase 2

Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8